La Jolla, Calif. (PRWEB) January 22, 2013
CHI-California Healthcare Institute announced today the election of David E.I. Pyott, chairman of the board, president and chief executive officer of Allergan, Inc., to serve as chairman of the CHI board of directors. CHI’s board also elected two new members: Richard J. Gregory, Ph.D., who serves as senior vice president and head of R&D for the Sanofi-Genzyme R&D Center, and Joshua J. Ofman, M.D., M.S.H.S., who serves as senior vice president of Global Value, Access and Policy for Amgen. CHI is a non-profit public policy research organization, representing leading California academic institutions, biotechnology, medical device, diagnostics and pharmaceutical firms.
“These veteran industry executives will help guide CHI’s approach to the important issues facing the biomedical community today,” said David L. Gollaher, Ph.D., CHI president and CEO. “From coverage and reimbursement to government funding of basic research, CHI’s leadership will be focused on advancing a policy agenda that helps sustain and strengthen California’s life sciences ecosystem.”
Pyott was elected to the CHI board in 1998, serving as its chairman in 2003-04. During his chairmanship, he was instrumental in strengthening CHI’s board and the organization’s financial position as well as focusing its political agenda in Washington and Sacramento.
Pyott joined Allergan in January 1998 as president and CEO and has transformed Allergan from a small eye care business to a global specialty pharmaceutical and medical device company with leadership positions in six medical specialties. In 2006, Pyott was bestowed with the honor of Commander of the Most Excellent Order of the British Empire (CBE) by Her Majesty the Queen in acknowledgement of his contribution to British business excellence and management skills in the United States. He was also recognized by Harvard Business Review as one of “The
Copyright©2012 Vocus, Inc.
All rights reserved